Matthias Versele

Leuven, VLG 3001, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

KRAS Can Bind to FTase Despite Disruption of the CAAX Binding Site.

KRAS Can Bind to FTase Despite Disruption of the CAAX Binding Site.

Journal: Biochemistry

Published: February 12, 2026

A small molecule allosterically activates SecA dependent secretion.

A small molecule allosterically activates SecA dependent secretion.

Journal: Communications biology

Published: July 02, 2025

Synthetic GPR84 Agonists in Colorectal Cancer: Effective in THP-1 Cells but Ineffective in BMDMs and MC38 Mouse Tumor Models.

Synthetic GPR84 Agonists in Colorectal Cancer: Effective in THP-1 Cells but Ineffective in BMDMs and MC38 Mouse Tumor Models.

Journal: International journal of molecular sciences

Published: December 09, 2024

Development and validation of a high-throughput screening pipeline of compound libraries to target EMT.

Development and validation of a high-throughput screening pipeline of compound libraries to target EMT.

Journal: Cell death and differentiation

Published: May 27, 2024

Ibetazol, a novel inhibitor of importin β1-mediated nuclear import.

Ibetazol, a novel inhibitor of importin β1-mediated nuclear import.

Journal: Communications biology

Published: May 08, 2024

ADAMTS12 promotes fibrosis by restructuring extracellular matrix to enable activation of injury-responsive fibroblasts.

ADAMTS12 promotes fibrosis by restructuring extracellular matrix to enable activation of injury-responsive fibroblasts.

Journal: The Journal of clinical investigation

Published: March 08, 2023

A Novel Irreversible TEAD Inhibitor, SWTX-143, Blocks Hippo Pathway Transcriptional Output and Causes Tumor Regression in Preclinical Mesothelioma Models.

A Novel Irreversible TEAD Inhibitor, SWTX-143, Blocks Hippo Pathway Transcriptional Output and Causes Tumor Regression in Preclinical Mesothelioma Models.

Journal: Molecular cancer therapeutics

Published: November 04, 2022

Stimulation of the atypical chemokine receptor 3 (ACKR3) by a small-molecule agonist attenuates fibrosis in a preclinical liver but not lung injury model.

Stimulation of the atypical chemokine receptor 3 (ACKR3) by a small-molecule agonist attenuates fibrosis in a preclinical liver but not lung injury model.

Journal: Cellular and molecular life sciences : CMLS

Published: January 11, 2022

Combining Cell Envelope Stress Reporter Assays in a Screening Approach to Identify BAM Complex Inhibitors.

Combining Cell Envelope Stress Reporter Assays in a Screening Approach to Identify BAM Complex Inhibitors.

Journal: ACS infectious diseases

Published: June 14, 2021

Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones.

Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones.

Journal: Cancer cell

Published: March 30, 2018

The effect of Bruton's tyrosine kinase (BTK) inhibitors on collagen-induced platelet aggregation, BTK, and tyrosine kinase expressed in hepatocellular carcinoma (TEC).

The effect of Bruton's tyrosine kinase (BTK) inhibitors on collagen-induced platelet aggregation, BTK, and tyrosine kinase expressed in hepatocellular carcinoma (TEC).

Journal: European journal of haematology

Published: March 28, 2018

Identification of potential ibrutinib combinations in hematological malignancies using a combination high-throughput screen.

Identification of potential ibrutinib combinations in hematological malignancies using a combination high-throughput screen.

Journal: Leukemia & lymphoma

Published: July 29, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026